Last reviewed · How we verify
Biocidan (CETHEXONIUM)
Biocidan (generic name: CETHEXONIUM) is a cethexonium bromide drug. It is currently in Phase 2 development.
Biocidan works by interacting with a specific biological target to produce a therapeutic effect.
Biocidan, also known as Cetexonium chloride, is a small molecule. Its exact mechanism and indications are not specified in the provided information.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | CETHEXONIUM |
|---|---|
| Drug class | cethexonium bromide |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 2 |
Mechanism of action
Imagine your body's cells have locks on them, and Biocidan has a key that fits into those locks. When it binds to the lock, it helps to regulate the activity of the cell, which can help to treat certain conditions. This is a simplified explanation of how Biocidan works at a molecular level.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Biocidan CI brief — competitive landscape report
- Biocidan updates RSS · CI watch RSS
Frequently asked questions about Biocidan
What is Biocidan?
How does Biocidan work?
What is the generic name of Biocidan?
What drug class is Biocidan in?
What development phase is Biocidan in?
Related
- Drug class: All cethexonium bromide drugs
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing